Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues

Published:2019-02 Issue: Volume:65 Page:37-55
ISSN:0098-2997
Container-title:Molecular Aspects of Medicine
language:en
Short-container-title:Molecular Aspects of Medicine

Author:

Parola Maurizio,Pinzani Massimo^ORCID

Funder

Italian Association for Cancer Research

NIHR BRCIII University College London

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference269 articles.

1. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension;Afdhal;J. Viral Hepat.,2017

2. Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease;Anstee;Gastroenterology,2016

3. The pathogenesis of autoimmune liver disease;Arndtz;Dig. Dis.,2016

4. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver;Asahina;Hepatology,2011

5. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury;Baeck;Gut,2012

Cited by 742 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guizhi Fuling Wan attenuates tetrachloromethane-induced hepatic fibrosis in rats via PTEN/AKT/mTOR signaling pathway;Journal of Ethnopharmacology;2024-11

2. The combination of paeoniflorin and metformin synergistically inhibits the progression of liver fibrosis in mice;European Journal of Pharmacology;2024-10

3. Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib);Life Sciences;2024-10

4. Glycyrrhizic acid ameliorates hepatic fibrosis by inhibiting oxidative stress via AKR7A2;Phytomedicine;2024-10

5. Spleen-liver dual accumulation of ly6clowExo potentiates synergistic immune modulation for liver fibrosis therapy;Nano Today;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3